- Home
- NEUP vs TXMD Comparison
NEUP vs TXMD Comparison
Compare NEUP & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- TXMD
- Stock Information
- Founded
- NEUP 1996
- TXMD 2008
- Country
- NEUP United States
- TXMD United States
- Employees
- NEUP N/A
- TXMD N/A
- Industry
- NEUP
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- NEUP
- TXMD Health Care
- Exchange
- NEUP Nasdaq
- TXMD Nasdaq
- Market Cap
- NEUP 12.7M
- TXMD 12.7M
- IPO Year
- NEUP N/A
- TXMD N/A
- Fundamental
- Price
- NEUP $11.89
- TXMD $1.07
- Analyst Decision
- NEUP Strong Buy
- TXMD
- Analyst Count
- NEUP 1
- TXMD 0
- Target Price
- NEUP $21.00
- TXMD N/A
- AVG Volume (30 Days)
- NEUP 67.0K
- TXMD 17.2K
- Earning Date
- NEUP 08-28-2025
- TXMD 08-12-2025
- Dividend Yield
- NEUP N/A
- TXMD N/A
- EPS Growth
- NEUP N/A
- TXMD N/A
- EPS
- NEUP 0.00
- TXMD N/A
- Revenue
- NEUP $15,662,715.00
- TXMD $2,559,000.00
- Revenue This Year
- NEUP N/A
- TXMD $427.09
- Revenue Next Year
- NEUP N/A
- TXMD N/A
- P/E Ratio
- NEUP $3.84
- TXMD N/A
- Revenue Growth
- NEUP N/A
- TXMD 156.93
- 52 Week Low
- NEUP $2.90
- TXMD $0.70
- 52 Week High
- NEUP $126.00
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- NEUP 67.40
- TXMD 42.48
- Support Level
- NEUP $6.82
- TXMD $1.05
- Resistance Level
- NEUP $13.25
- TXMD $1.12
- Average True Range (ATR)
- NEUP 1.32
- TXMD 0.04
- MACD
- NEUP 0.44
- TXMD -0.00
- Stochastic Oscillator
- NEUP 77.78
- TXMD 15.46
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.